Travere Therapeutics
201 - 500 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Travere Therapeutics is a biopharmaceutical company committed to identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those related to rare kidney and metabolic disorders. The company has a strong focus on advancing science in these fields, with a pipeline that includes treatments for conditions such as IgA nephropathy and focal segmental glomerulosclerosis. With the full U. S. FDA approval of its non-immunosuppressive treatment for IgA nephropathy, Travere Therapeutics continues to set new standards of care. The company collaborates with the rare kidney disease community, including patient advocacy organizations and clinical trial investigators, to bring hope to patients with these serious conditions.
Director, Scientific Engagement – Professional Societies
🕒 March 6
📊 Check your resume score for this job
Improve your chances of getting an interview by checking your resume score before you apply.
Travere Therapeutics
201 - 500 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Travere Therapeutics is a biopharmaceutical company committed to identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those related to rare kidney and metabolic disorders. The company has a strong focus on advancing science in these fields, with a pipeline that includes treatments for conditions such as IgA nephropathy and focal segmental glomerulosclerosis. With the full U. S. FDA approval of its non-immunosuppressive treatment for IgA nephropathy, Travere Therapeutics continues to set new standards of care. The company collaborates with the rare kidney disease community, including patient advocacy organizations and clinical trial investigators, to bring hope to patients with these serious conditions.
📋 Description
• Develop and execute a multi-year engagement strategy across major nephrology organizations • Serve as the primary Medical Affairs lead for professional societies and their scientific advisory councils • Expand engagement beyond sponsorships & annual congresses to sustained, strategic collaboration • Lead engagement strategy with guideline committees and compendia decision-makers • Partner with Ev Gen, Clinical Development, HEOR, and Scientific Communications to align evidence generation and publication timing • Define KPIs that measure impact beyond sponsorship metrics
🎯 Requirements
• Advanced scientific degree (MD, PharmD, PhD) • 6+ years Medical Affairs experience in biopharma, ideally within nephrology or rare disease • Experience engaging professional societies, guideline bodies, and/or scientific advisory councils • Demonstrated success building external partnerships beyond transactional sponsorships • Strong cross-functional leadership skills, particularly across Advocacy and Government Affairs • Strategic thinker with the ability to identify white-space opportunities and build structured initiatives
🏖️ Benefits
• premium health • financial • work-life and well-being offerings for eligible employees and dependents • wellness and employee support programs • life insurance • disability • retirement plans with employer match • generous paid time off
Apply NowSimilar Jobs
🕒 March 6
Director of AWS Cloud Alliances at Impact Advisors managing partnerships with AWS. Focused on driving growth through alliance strategy and joint go-to-market execution.
🕒 March 4
Director of IT PMO leading project and program management team delivering transformational IT initiatives at Resonant. Overseeing large-scale IT initiatives and ensuring alignment with business goals.
🕒 March 4
Serve as delivery leader for North American utility transformation at Kraken. Lead implementation programs and client relations to enhance operational effectiveness in energy sector.
🕒 March 4
ZEISS Group
10,000+ employees
Director of Vision Care Solutions overseeing U.S. VCS strategy while ensuring compliance and team development for ZEISS in optical health.
🕒 March 4
Scientific Director at Prudentia Sciences shaping scientific strategy for an AI-driven platform impacting portfolio management. Engaging directly with biopharma to drive scientific rigor and decision-making.
